Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls

By sjmartinez • March 12, 2024

Chen K, Jackson NJ, Kelesidis T. Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls. EBioMedicine. 2024 Mar 7:105042. doi: 10.1016/j.ebiom.2024.105042. Epub ahead of print. PMID: 38471990.

Tags: Antiviral treatment, clinical trials, covid-19, General Internal Medicine, Mitochondrial antioxidants, Post-exposure prophylaxis, Publications, SARS-CoV-2 infection, Translational research

Broad repetitive transcranial magnetic stimulation (rTMS) of the precuneus in Alzheimer’s disease: A rationale and study design

Leuchter MK, Oughli HA, Durbin KA, Jackson NJ, Elashoff D, Chang TS, Corlier J, Ngo D, Matthews C, Wong D, Fogel BL, Bitan G, Leuchter[...]

An Urgent Need to Improve Accessibility of Preventive Services for People With Disabilities

Hotez E, Duan S, Ma J, Shankar S. An Urgent Need to Improve Accessibility of Preventive Services for People With Disabilities. Ann Intern Med. 2025[...]

COVID-19 Pandemic and the Developmental Health of Kindergarteners

Perrigo JL, Morales J, Jackson N, Janus M, Stanley L, Wong M, Halfon N. COVID-19 Pandemic and the Developmental Health of Kindergarteners. JAMA Pediatr. 2025[...]